Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP19A1 | P11511 | 7/20 | 0.41 |
| ▸ | MAOB | P27338 | 6/20 | 0.36 |
| ▸ | DAO | P14920 | 1/20 | 0.34 |
| ▸ | RIPK1 | Q13546 | 3/20 | 0.33 |
| ▸ | KIF11 | P52732 | 1/20 | 0.33 |
| ▸ | LTB4R | Q15722 | 1/20 | 0.33 |
| ▸ | LTB4R2 | Q9NPC1 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8470417 | 0.86 | CYP19A1 (0.50) | CYP19A1MAOB | |
| SCHEMBL8472084 | 0.86 | CYP19A1 (0.40) | CYP19A1MAOBDAORIPK1LTB4R | |
| SCHEMBL8470385 | 0.85 | CYP19A1 (0.47) | CYP19A1MAOB | |
| SCHEMBL8472750 | 0.83 | CYP19A1 (0.53) | CYP19A1 | |
| SCHEMBL8470905 | 0.70 | CYP19A1 (0.34) | CYP19A1 | |
| SCHEMBL2172499 | 0.70 | CYP19A1 (0.45) | CYP19A1MAOBLTB4RLTB4R2 | |
| SCHEMBL28454916 | 0.68 | CYP19A1 (0.39) | CYP19A1MAOB | |
| SCHEMBL28454919 | 0.68 | CYP19A1 (0.39) | CYP19A1MAOB | |
| SCHEMBL8470357 | 0.68 | CYP19A1 (0.52) | CYP19A1MAOBKIF11LTB4RLTB4R2 | |
| SCHEMBL28948130 | 0.64 | CYP19A1 (0.40) | CYP19A1MAOBLTB4RLTB4R2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5886016-A | ANTIINFLAMMATORY AGENT WITH MINIMAL SIDE EFFECTS FOR TREATING ARTHRITIS | G.D. SEARLE & CO. (US) | 1999-03-23 | — | — | US | disclosed |
| US-5670532-A | Pyrazolyl derivatives for the treatment of inflammation | G. D. SEARLE & CO. (US) | 1997-09-23 | — | — | US | disclosed |
| US-5565482-A | ANTIINFLAMMATORY AGENTS, ANTIARTHRITIC AGENTS | G.D. SEARLE & CO. (US) | 1996-10-15 | — | — | US | disclosed |
| US-5547975-A | ANTIARTHRIC AGENTS, ANALGESICS AND ANTIPYRETICS; INHIBITORS OF CYCLOOXYGENASE II; SIDE EFFECT REDUCTION | G.D. SEARLE & CO. | 1996-08-20 | — | — | US | disclosed |
| WO-1996009304-A1 | BENZOPYRANOPYRAZOLYL DERIVATIVES FOR THE TREATMENT OF INFLAMMATION | G.D. SEARLE & CO. (US) | 1996-03-28 | — | — | WO | disclosed |